HO prevention and the combined therapeutic protocol - Do we really need it? [3]

International Orthopaedics

Volumn 31, Issue 1, 2007, Pages 133-134

  Kose, Kamil Cagri ^a,b   Cebesoy, Oguz ^a   Altinel, Levent ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; BODY MASS; HETEROTOPIC OSSIFICATION; HIP ARTHROPLASTY; HIP FRACTURE; HUMAN; LETTER; MEDICAL LITERATURE; OPERATION DURATION; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOMETHACIN; MALE; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 33846813912     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-006-0199-3     Document Type: Letter

References (6)

1. Ashton LA, Bruce W, Goldberg J, Walsh W (2000) Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty. J Orthop Surg (Hong Kong) 8(2):53-57
2. D'Lima DD, Venn-Watson EJ, Tripuraneni P, Colwell CW (2001) Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty. Orthopedics 24(12):1139-1143
3. Handel M, Brettschneider J, Kock FX, Anders S, Perlick L, Sell S (2004) Risk factors associated with heterotopic ossifications in primary total hip arthroplasty. Z Orthop Ihre Grenzgeb 142(5):564-570
4. Moed BR, Letournel E (1994 ) Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. J Bone Joint Surg Br 76(6):895-900
5. Pakos EE, Pitouli EJ, Tsekeris PG, Papathanasopoulou V, Stafilas K, Xenakis TH (2006) Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 30(2):79-83
6. Zehetgruber H, Grubl A, Goll A, Schwameis E, Wurnig C, Giurea A (2005) Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors. Z Orthop Ihre Grenzgeb 143(6):631-637